iBio Appoints Dr. Martin B. Brenner as Chief Scientific Officer
[December 28, 2020] iBio Appoints Dr. Martin B. Brenner as Chief Scientific Officer BRYAN, Texas, Dec. 28, 2020 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (âiBioâ or the âCompanyâ), a biotech innovator and biologics contract manufacturing organization, today announced the appointment of Martin B. Brenner, DVM, Ph.D., as its Chief Scientific Officer (âCSOâ), effective January 18, 2020. âWe are thrilled to have Dr. Brenner join our team,â said Tom Isett, Chairman & CEO of iBio. âGiven his prior experience leading organizations with novel protein exp...
Source: tmcnet.com